Home Corium

Corium

acquired
IPO Delisting
Developer of Central Nervous System Health Therapies

Basic Information

Corium is a commercial-stage biopharmaceutical company leading the development and commercialization of therapies for central nervous system care, providing important treatment options for clinicians, patients and their families, and caregivers.
Corium Inc.
Cambridge,Massachusetts,United States of America
more than 500 people
January 01, 1995
--